B-cell depletion therapy using rituximab in neuromyelitis optica spectrum disorders

被引：0
|
作者：
Kim, H. J.
Kim, W.
Park, M. S.
Ha, C. K.
Jung, I. J.
Lee, K. I.
机构：
[1] Natl Canc Ctr, Goyang, South Korea
[2] Yeungnam Univ Hosp, Taegu, South Korea
[3] Inha Univ Hosp, Inchon, South Korea
来源：
MULTIPLE SCLEROSIS | 2009年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S253 / S254
页数：2
相关论文
共 50 条
  • [1] Duration of B-cell depletion in patients receiving ocrelizumab or rituximab for Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorders
    AbdelRazek, M. A.
    Casasola, M.
    Mollashahi, R.
    Brodski, A.
    Morin, S.
    Augustynowicz, A.
    Jassim, S.
    Matiello, M.
    Sloane, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 100 - 100
  • [2] Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder
    Sechi, Elia
    Zarbo, Roberto
    Biancu, Maria Angela
    Chessa, Paola
    Idda, Maria Laura
    Orru, Valeria
    Lai, Sandra
    Leoni, Stefania
    Solla, Paolo
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2021, 358
  • [3] Correlation of B-cell depletion and disease activity after treatment with rituximab in patients with neuromyelitis optica
    Pellkofer, H. L.
    Hohlfeld, R.
    Kuempfel, T.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S130 - S131
  • [4] Low-dose Rituximab therapy for neuromyelitis optica spectrum disorders
    Novo, A.
    Correia, I.
    Marques, I.
    Batista, S.
    Sousa, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 542 - 542
  • [5] Tailoring Rituximab according to memory B-cell vs B-cell monitoring in Neuromyelitis Optica Spectrum Disorder and MOGAD
    Bruschi, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 636 - 636
  • [6] Severe Relapse Despite B-Cell Depletion in Neuromyelitis Optica
    Riley, Claire
    Tullman, Mark
    [J]. NEUROLOGY, 2010, 74 (09) : A171 - A171
  • [7] Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders
    McKeon, Andrew
    Pittock, Sean
    [J]. JAMA NEUROLOGY, 2013, 70 (09) : 1102 - 1104
  • [8] Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
    Jade, Jui Dilip
    Bansi, Srishti
    Singhal, Bhim
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2017, 20 (03) : 229 - 232
  • [9] Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
    Ciron, J.
    Audoin, B.
    Bourre, B.
    Brassat, D.
    Durand-Dubief, F.
    Laplaud, D.
    Maillart, E.
    Papeix, C.
    Vukusic, S.
    Zephir, H.
    Marignier, R.
    Collongues, N.
    [J]. REVUE NEUROLOGIQUE, 2018, 174 (04) : 255 - 264
  • [10] Psoriasis induced by Rituximab in Neuromyelitis Optica Spectrum Disorders
    Cheng, S.
    Li, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP94 - NP94
12345